Molecular mechanisms of insulin resistance in IRS-2-deficient hepatocytes

Diabetes

Volumn 52, Issue 9, 2003, Pages 2239-2248

  Valverde, Angela M ^a   Burks, Deborah J ^b   Fabregat, Isabel ^a   Fisher, Tracey L ^c   Carretero, José ^b   White, Morris F ^c   Benito, Manuel ^a  

^a Instituto de Bioquimica   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CARBAMOYL PHOSPHATE SYNTHASE; GLUCOSE 6 PHOSPHATASE; GLYCOGEN SYNTHASE KINASE 3; INSULIN RECEPTOR SUBSTRATE 2; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PROTEIN; PROTEIN KINASE B; PROTEIN KINASE C; PYRUVATE KINASE; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MEMBRANE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; GENOTYPE; GLUCONEOGENESIS; HORMONE ACTION; INSULIN RELEASE; INSULIN RESISTANCE; LIVER; LIVER CELL; MOUSE; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADENOVIRIDAE; ANIMALS; ANIMALS, NEWBORN; ANTIGENS, POLYOMAVIRUS TRANSFORMING; CELL LINE, TRANSFORMED; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GLUCONEOGENESIS; GLUCOSE-6-PHOSPHATASE; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3; HEPATOCYTES; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOENZYMES; MALE; MICE; MICE, MUTANT STRAINS; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); PHOSPHOPROTEINS; PREGNANCY; PROTEIN KINASE C; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RETROVIRIDAE; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 0042822138     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.9.2239     Document Type: Article

References (57)

1. Saltiel RA: New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 104:517-529, 2001
2. Kadowaki T: Insights into insulin resistance and type 2 diabetes from knockout mouse models. J Clin Invest 106:459-465, 2000
3. White MF: IRS proteins and the common path to diabetes. Am J Physiol Endocrinol Metab 283:E413-E422, 2002
4. Tarnemoto H, Kadowaki T, Tobe K, Yagi T, Sakura H, Hayakawa T, Terauchi Y, Ueki K, Yaburagi Y, Satoh S, Sekihara H, Yoshioka S, Horikoshi H, Furuta Y, Ikawa Y, Kasuga M, Yazaki Y, Aizawa S: Insulin resistance and growth retardation in mice made with targeted disruption of the IRS-1 gene. Nature 372:182-186, 1994
5. Araki E, Lipes MA, Patti ME, Brüning JC, Haag BL III, Johnson RS, Kahn CR: Alternative pathway of insulin signaling in mice made with targeted disruption of the IRS-1 gene. Nature 372:186-190, 1994
6. Withers DJ, Gutierrez JS, Towery H, Burks DJ, Ren JM, Previs S, Zhang Y, Bernal D, Pons S, Shulman GI, Bonner-Weir S, White MF: Disruption of IRS-2 causes type 2 diabetes in mice, Nature 391:900-904, 1998
7. Kubota N, Tobe K, Terauchi Y, Eto K, Yamauchi T, Suzuki R, Tsubamoto Y, Komeda K, Nakano R, Miki, H, Satoh S, Sekihara H, Sciacchitano S, Lesniak M, Aizawa S, Nagai R, Kimura S, Akanuma Y, Taylor SI, Kadowaki T: Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory β-cell hyperplasia. Diabetes 49:1880-1889, 2000
8. Sun XJ, Wang LM, Zhang Y, Yenush L, Myers MG Jr, Glasheen E, Lane WS, Pierce JH, White MF: Role of IRS-2 in insulin and cytokine signaling. Nature 377:173-177, 1995
9. Tobe K, Tamemoto H, Yamauchi T, Aizawa S, Yazaki Y, Kadowaki T: Identification of a 190-kDa protein as a novel substrate for the insulin receptor kinase functionally similar to insulin receptor substrate-1. J Biol Chem 270:5698-5701, 1995
10. Kido Y, Burks DJ, Withers D, Brunning JC, Kahn CR, White MF, Accili D: Tissue-specific insulin resistance in mice with combined mutations of the insulin receptor. J Clin Invest 105:199-205, 2000
11. Yamauchi T, Tobe K, Tamemoto H, Ueki K, Kaburagi Y, Yamamoto-Honda R, Takahashi Y, Yoshizawa F, Aizawa S, Akanuma Y, Sonenberg N, Yazaki Y, Kadowaki T: Insulin signaling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate-1-deficient mice. Mol Cell Biol 16:3074-3084, 1996
12. Higaki Y, Wojtaszewski JF, Hirshman MF, Withers DJ, Towery H, White MF, Goodyear LJ: Insulin receptor substrate-2 is not necessary for insulinand exercise-stimulated glucose transport in skeletal muscle. J Biol Chem 274:20791-20795, 1999
13. Kahn CR, Bruning JC, Michael MD, Kulkarni RN: Knockout mice challenge our concepts of glucose homeostasis and the pathogenesis of diabetes mellitus. J Pediatr Endocrinol Metab 13 (Suppl. 6):1377-1384, 2000
14. Virkamäki A, Ueki K, Kahn CR: Protein-protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 103:931-943, 1999
15. Backer JM, Myers MG Jr, Schoelson SE, Chin DJ, Sun XJ, Miralpeix M, Hu P, Margolis B, Skolnik EY, Schlessinger J, White MF: The phosphatidylinositol 3-kinase is activated by association with IRS-1 during insulin stimulation. EMBO J 11:3469-3479, 1992
16. Kim YB, Nikoulina SE, Ciaraldi TP, Henry RR, Kahn BB: Normal insulin-dependent activation of Akt/protein kinase B, with diminished activation of phosphoinositide 3-kinase, in muscle in type 2 diabetes. J Clin Invest 104:733-741, 1999
17. Heydrick SJ, Jullien D, Gautier N, Tanti JF, Giorgetti S, Van Obberghen E, Le Marchand-Brustel Y: Defect in skeletal muscle phosphatidylinositol-3-kinase in obese insulin-resistant mice. J Clin Invest 91:1358-1366, 1993
18. Tsuchida A, Nakagawa T, Itakura Y, Ichihara J, Ogawa W, Kasuga M, Taiji M, Noguchi H: The effects of brain-derived neurotrophic factor on insulin signal transduction in the liver of diabetic mice. Diabetologia 44:555-566, 2001
19. Summers SA, Kao AW, Kohn AD, Backus GS, Roth RA, Pessin JE, Birnbaum MJ: The role of glycogen synthase kinase 3 beta in insulin-stimulated glucose metabolism. J Biol Chem 274:17934-17940, 1999
20. Sutherland C, O'Brien RM, Granner DK: Phosphatidylinositol 3-kinase, but not p70/p85 ribosomal S6 protein kinase, is required for the regulation of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by insulin: dissociation of signaling pathways for insulin and phorbol ester regulation of PEPCK gene expression. J Biol Chem 270:15501-15506, 1995
21. Gabbay RA, Sutherland C, Gnudi L, Kahn BB, O'Brien RM, Granner DK, Flier JS: Insulin regulation of phosphoenolpyruvate carboxykinase gene expression does not require activation of the Ras/mitogen-activated protein kinase signaling pathway. J Biol Chem 271:1890-1897, 1996
22. Dickens M, Svitek CA, Culbert AA, O'Brien RM, Tavaré JM: Central role for phosphatidylinositide 3-kinase in the repression of glucose-6-phosphatase gene transcription by insulin. J Biol Chem 273:20144-20149, 1998
23. Kotani K, Ogawa W, Hino Y, Kitamuta T, Ueno H, Sano W, Sutherland C, Granner DK, Kasuga M: Dominant negative forms of Akt (protein kinase B) and atypical protein kinase Cl do not prevent insulin inhibition of phosphoenolpyruvate carboxykinase gene transcription. J Biol Chem 274:21305-21312, 1999
24. Fabregat I, Lorenzo, Benito M: Precocious induction of malic enzyme by nutritional and hormonal factors in rat foetal hepatocyte primary cultures. Biochem Biophys Res Commun 161:1028-1034, 1989
25. Valverde AM, Lorenzo M, Navarro P, Benito M: Phosphatidylinositol 3-kinase is a requirement for insulin-like growth factor-I-induced differentiation, but not for mitogenesis, in fetal brown adipocytes. Mol Endocrinology 11:595-607, 1997
26. Lopez-Delgado MI, Morales M, Villanueva-Peñacarrillo ML, Malaisse WJ, Valverde I: Effects of glucagon-like peptide 1 on the kinetics of glycogen synthase a in hepatocytes from normal and diabetic rats. Endocrinology 139:2811-2817, 1998
27. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities utilizing the principle of protein dye binding. Anal Biochem 72:248-254, 1976
28. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159, 1987
29. Kavran JM, Klein DE, Lee A, Falasca M, Isakoff SJ, Skolnik EY, Lemmon MA: Specificity and promiscuity in phosphoinositide binding by pleckstrin homology domains. J Biol Chem 273:30497-30508, 1998
30. Langille SE, Patki V, Klarlund JK, Buxton JM, Holik JJ, Chawla A, Corvera S, Czech M: ADP-ribosylation factor 6 as a target of guanine nucleotide exchange factor GRP1. J Biol Chem 274:27099-27104, 1999
31. Czech M: PIP2 and PIP3: complex roles at the cell surface. Cell 100:603-606, 2000
32. Standaert ML, Galloway L. Karman P, Bandyopadhyay G, Moscat J, Farese RV: Protein kinase C ζ as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes: potential role in glucose transport. J Biol Chem 272:30075-30082, 1997
33. Bandyopadhyay G, Kanoh Y, Sajan MP, Standaert ML, Fareese RV: Effects of adenoviral gene transfer of wild-type, constitutively active, and kinase-defective protein kinase C-λ on insulin-stimulated glucose transport in L6 myotubes. Endocrinology 141:4120-4127, 2000
34. Valverde AM, Lorenzo M, Navarro P, Mur C, Benito M: Okadaic acid inhibits insulin-induced glucose transport in fetal brown adipocytes in an Akt-independent and protein kinase C ζ-dependent manner. FEBS Lett 472:153-158, 2000
35. Nakae J, Kitamura T, Silver DL, Accili D: The forkhead transcription factor foxol (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. J Clin Invest 108:1359-1367, 2001
36. Withers DJ, Burks DJ, Towery HH, Altamuro SL, Flint CL, White MF: IRS-2 coordinates IGF-I receptor-mediated β-cell development and peripheral insulin signaling. Nat Genet 23:32-40, 1999
37. Somwar R, Sumitani S, Taha C, Sweeney G, Klip A: Temporal activation of p70 S6 kinase and aktl by insulin: PI 3-kinase-dependent and -independent mechanisms. Am J Physiol 4:E618-E625, 1998
38. Pende M, Kozma SC, Jaquet M, Oorschot V, Burcelin R, Le Marchand-Brustel Y, Klumperman J, Thorens B, Thomas G: Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6Kl-deficient mice. Nature 408:994-997, 2000
39. Miyake K, Ogawa W, Matsumoto M, Nakamura T, Sakaue H, Kasuga M: Hyperinsulinemia, glucose intoleranee, and dyslipidemia induced by acute inhibition of phosphoinositide 3-kinase signaling in the liver. J Clin Invest 110:1483-1491, 2002
40. Rother KI, Imai Y, Caruso M, Beguinot F, Formisano P, Accili D: Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes. J Biol Chem 273:17491-17497, 1998
41. Oriente F, Formisano P, Miele C, Fiory F, Maitan MA, Vigliotta G, Trencia A, Santopietro S, Caruso M, Van Obberghen E, Beguinot F: Insulin receptor substrate-2 phosphorylation is necessary for protein kinase C ζ activation by insulin in L6hIR cells. J Biol Chem 276:37109-37119, 2001
42. Cline GW, Johnson K, Regitting W, Perret P, Tozzo E, Xiao L, Damico C, Shulman GI: Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats. Diabetes 51:2903-2910, 2002
43. Valera A, Pujol A, Pelegrin M, Bosch F: Transgenic mice overexpressing phosphoenolpyruvate carboxykinase develop non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 91:9151-91154, 1994
44. Trinh KY, O'Doherty RM, Anderson P, Lange AJ, Newgard CB: Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats. J Biol Chem 273:31615-31620, 1998
45. Previs SF, Withers DJ, Ren JM, White MF, Shulman GI: Contrasting effeets of IRS-1 versus IRS-2 gene disruption on carbohydrate and lipid metabolism in vivo. J Biol Chem 275:38990-38994, 2000
46. Michael MD, Kulkarni RN, Postic C, Previs SF, Schulman GI, Magnuson MA, Kahn CR: Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 6:87-97, 2000
47. Sun Y, Liu S, Ferguson S, Wang L, Klepcyk P, Yun JS, Friedman JE: Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice. J Biol Chem 277:23301-23307, 2002
48. Park EA, Gurney AL, Nizielski SE, Hakimi P, Cao Z, Moorman A, Hanson RW: Relative roles of CCAAT/enhancer-binding protein beta and cAMP regulatory element-binding protein in controlling transcription of the gene for phosphoenolpyruvate carboxykinase (GTP). J Biol Chem 268:613-619, 1993
49. Ferre T, Riu E, Bosch F, Valera A: Evidence from transgenic mice that glucokinase is rate limiting for glucose utilization in the liver. FASEB J 10:1213-1218, 1996
50. Nakae J, Biggs WH III, Kitanmra T, Cavenee WK, Wright CE, Arden KC, Accili D: Regulation of insulin action and pancreatic β-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nat Genet 32:245-253, 2002
51. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arder KC, Bleni J, Greenberg ME: Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 96:857-868, 1999
52. Biggs WH, Meisenhelder J, Hunter T, Cavenee WK, Arden KC: Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the single helix transcription factor FKHRL1. Proc Natl Acad Sci U S A 96:7421-7426, 1999
53. Del Peso L, Gonzalez VM, Hernandez R, Barr FG, Nuñez G: Regulation of the forkhead transcription factor FKHR, but not the PAX3-FKHR fusion protein, by the serine/threonine kinase Akt. Oncogene 18:7328-7333, 1999
54. Hall RK, Yamasaki T, Kucera T, Waltner-Law M, O'Brien R, Granner DK: Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. J Biol Chem 275 30169-30175, 2000
55. Schmoll D, Walker KS, Alessi D, Grempler R, Burchell A, Guo S, Walther R, Unterman TG: Regulation of glucose-6-phosphatase gene expression by protein kinase B alpha and the forkhead transcription factor FKHR. J Biol Chem 275:36324-36333, 2000
56. Daitoku H, Yamagata K, Matsuzaki H, Hatta M, Fukamizu A: Regulation of PGC-1 promoter activity by protein kinase B and the forkhead transcription factor FKHR. Diabetes 52:642-649, 2003
57. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM: Control of hepatic gluconeogenesis through the coactivator PGC-1. Nature 413:131-138, 2001